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Abstract
Purpose Supra-tolerance head-to-foot directed gravitoinertial load (+Gz) typically induces a sequence of
symptoms/ signs, including loss of: peripheral vision—central vision— consciousness. The risk of
unconsciousness is greater when anti-G-garment failure occurs after prolonged rather than brief exposures,
presumably because, in the former condition, mental signs are not consistently preceded by impaired vision.
The aims were to investigate if prolonged exposure to moderately elevated +Gz reduces intraocular pressure
(IOP; i.e., improves provisions for retinal perfusion), or the cerebral anoxia reserve. Methods Subjects were
exposed to 4-min +Gz plateaux either at 2 and 3 G (n = 10), or at 4 and 5 G (n = 12). Measurements included
eye-level mean arterial pressure (MAP), oxygenation of the cerebral frontal cortex, and at 2 and 3 G, IOP.
Results IOP was similar at 1 (14.1 ± 1.6 mmHg), 2 (14.0 ± 1.6 mmHg), and 3 G (14.0 ± 1.6 mmHg). During
the G exposures, MAP exhibited an initial prompt drop followed by a partial recovery, end-exposure values
being reduced by ≤30 mmHg. Cerebral oxygenation showed a similar initial drop, but without recovery, and
was followed by either a plateau or a further slight decrement to a minimum of about −14 μM. Conclusion Gz
loading did not affect IOP. That cerebral oxygenation remained suppressed throughout these G exposures,
despite a concomitant partial recovery of MAP, suggests that the increased risk of unconsciousness upon G-
garment failure after prolonged +Gz exposure is due to reduced cerebral anoxia reserve.
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similar initial drop, but without recovery, and was followed 
by either a plateau or a further slight decrement to a mini-
mum of about −14 μM.
Conclusion Gz loading did not affect IOP. That cerebral 
oxygenation remained suppressed throughout these G 
exposures, despite a concomitant partial recovery of MAP, 
suggests that the increased risk of unconsciousness upon 
G-garment failure after prolonged +Gz exposure is due to 
reduced cerebral anoxia reserve.
Keywords Cerebral anoxia reserve · Cerebral blood 
flow · G tolerance · G-induced loss of consciousness · 
Oxyhaemoglobin saturation · Retinal anoxia reserve
Abbreviations
ABD  With the full anti-G suit (including the abdomi-
nal bladder) pressurised
AGE 39  Anti-G ensemble used in the Gripen 39 aircraft
AGS  Anti-G suit
A-LOC  Almost G-induced loss of consciousness
DAP  Diastolic arterial pressure
∆[Hb]  Change in deoxygenated haemoglobin
∆[O2Hb]  Change in oxygenated haemoglobin
∆[THb]  Change in total haemoglobin
G  Dimensionless quantity denoting the ratio 
between the vector sum of gravitational and 
inertial forces and Earths gravity
G-LOC  G-induced loss of consciousness
+Gz  Gravitoinertial force in the head-to-foot 
direction
Hb  Haemoglobin
HR  Heart rate
IOP  Intraocular pressure
MAP  Mean arterial pressure
NIRS  Near infrared spectroscopy
Abstract 
Purpose Supra-tolerance head-to-foot directed gravitoiner-
tial load (+Gz) typically induces a sequence of symptoms/
signs, including loss of: peripheral vision—central vision—
consciousness. The risk of unconsciousness is greater 
when anti-G-garment failure occurs after prolonged rather 
than brief exposures, presumably because, in the former 
condition, mental signs are not consistently preceded by 
impaired vision. The aims were to investigate if prolonged 
exposure to moderately elevated +Gz reduces intraocular 
pressure (IOP; i.e., improves provisions for retinal perfu-
sion), or the cerebral anoxia reserve.
Methods Subjects were exposed to 4-min +Gz plateaux 
either at 2 and 3 G (n = 10), or at 4 and 5 G (n = 12). 
Measurements included eye-level mean arterial pressure 
(MAP), oxygenation of the cerebral frontal cortex, and at 
2 and 3 G, IOP.
Results IOP was similar at 1 (14.1 ± 1.6 mmHg), 2 
(14.0 ± 1.6 mmHg), and 3 G (14.0 ± 1.6 mmHg). Dur-
ing the G exposures, MAP exhibited an initial prompt drop 
followed by a partial recovery, end-exposure values being 
reduced by ≤30 mmHg. Cerebral oxygenation showed a 
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NoABD  With the anti-G suit (excluding the abdominal 
bladder) pressurised
NoAGS  Without the anti-G suit
SACM  Simulated aerial combat manoeuvres
SAP  Systolic arterial pressure
SpO2  Capillary oxyhaemoglobin saturation
Introduction
A major challenge for pilots flying high-performance air-
craft is to maintain adequate retinal and cerebral blood 
flow during headward acceleration. Thus, high gravitoin-
ertial load in the head-to-seat direction (+Gz; henceforth, 
G denotes +Gz unless otherwise stated) creates exagger-
ated intravascular pressure gradients. At 9 G, for instance, 
heart-level arterial pressure needs to be elevated to 225–
275 mmHg to preserve blood perfusion of the brain and 
retina. The pilots’ arterial pressure is increased by muscular 
straining manoeuvres in combination with pressurisation of 
the anti-G suit and, in modern high-performance aircraft, 
of the breathing gas (Green 2016). Upon a gradual increase 
in G load, a sequence of symptoms and signs evolves that 
determines the G-tolerance threshold; the sequence starts 
with loss of peripheral vision, is followed by loss of central 
vision and eventually by loss of consciousness (G-LOC). 
That critical ischaemia is attained at lower G load for the 
retina than for the cerebral cortex is attributable to two 
mechanisms. First, to perfuse the retina, arterial pres-
sure at eye level must be sufficient to overcome intraocu-
lar pressure (IOP) (Duane 1954; Lambert and Wood 1946; 
Newsom and Leverett 1968). Second, at increased G load, 
the “siphone effect” within intracranial vasculature is capa-
ble of facilitating perfusion of the cerebral cortex even 
when local arterial pressure drops to zero or sub-zero lev-
els (Henry et al. 1951), thereby sustaining adequate tissue 
oxygenation.
To date, the vast majority of studies regarding the 
influence of excessive G loads on vision and mental per-
formance have been conducted with the G load being ele-
vated from about 1 G to a level exceeding the tolerance 
threshold. In such conditions, the period of severe retinal 
or cerebral ischaemia is preceded by normal tissue oxy-
genation. We have, however, found that the sequence of 
signs and symptoms upon exposure to a supra-tolerance 
G load may be affected by the immediate G history pre-
ceding the high-G exposure. Thus, experienced fighter 
pilots were exposed to supra-tolerance G loads either by 
removing pressure in the G-protective system (anti-G suit 
and breathing mask) after a prolonged period (2 min) of 
sustained high-G loading or by rapidly applying such G 
loading, without pressurising the G-protective system; 
the pilots were instructed to terminate the G exposure 
upon loss of peripheral vision. The risk of losing con-
sciousness was several-fold higher when the pressure in 
the G-protective system was lost after 2 min of high-G 
loading, than when pressure failed to increase in conjunc-
tion with the onset of high G (Eiken and Grönkvist 2013). 
Presumably, the increased risk of G-LOC in the former 
condition is due to the fact that after a period of elevated 
but tolerable G load, warning symptoms in terms of 
reduced vision do not as distinctly precede G-LOC. This 
has obvious practical implications, since fighter pilots 
commonly use the loss of peripheral vision to gauge the 
tolerable G load. That a prolonged period of high-G load 
alters the tissue most susceptible to G-induced ischaemia 
from the peripheral retina to the cerebral cortex may, in 
turn, be either due to improved provisions for retinal per-
fusion (i.e., reduced IOP), or to a more pronounced drop 
of the tissue oxygen reserve in the cerebral cortex than in 
the retina.
Accordingly, the aims of the present study were to inves-
tigate if prolonged exposure to moderately elevated G force 
reduces either the IOP or the cerebral anoxia reserve. These 
possibilities were addressed in two separate series of experi-
ments. For practical and safety reasons, IOP was determined 
at ≤3G (series 1), whereas cerebral oxygenation was pre-
dominantly investigated at 4 and 5 G (series 2), because it is 
known that such G loading may induce substantial hypox-
aemia (Barr 1963). Since the anti-G suit, and in particular 
its abdominal bladder, appears to aggravate the G-induced 
hypoxaemia (Barr 1963; Eiken et al. 2011), we investi-
gated effects of prolonged G exposures with and without 
the abdominal bladder included in the suit inflation. Cere-
bral oxygenation was investigated using a transcranial Near 
Infrared Spectroscopy (NIRS) technique; the relative drop 
in frontal cortex oxygenation, as determined by NIRS, has 
been shown to be a valid risk predictor of G-LOC (Benni 
et al. 2003; Ryoo et al. 2004; Tripp et al. 2009).
Methods
Two series of experiments were performed, first, with 
exposures at 2 and 3 G, addressing the question of changes 
in IOP and second, with exposures at 4 and 5 G, focussing 
on the question of cerebral anoxia reserve (Fig. 1). Alto-
gether, 17 healthy individuals (16 men and one woman) 
participated as subjects, five of whom took part in both 
experimental series. They gave their written, informed con-
sent prior to enrolling, and were aware that they were free 
to withdraw from the study at any time. The protocol and 
experimental procedures were approved by the Regional 
Human Ethics Committee in Stockholm, Sweden.
The experiments were performed in the 7.25-m radius 
human-use centrifuge (ASEA, Västerås, Sweden) at the 
63Eur J Appl Physiol (2017) 117:61–72 
1 3
Royal Institute of Technology in Stockholm. During each 
experiment, the subject was seated in the centrifuge gon-
dola, in a “mock” of the Gripen 39 seat, which has a back 
angle reclining 28° from the vertical. The centrifuge was 
controlled by an “open-loop” system, employing pre-set 
G-time profiles. Gz was measured using an analogue accel-
erometer mounted in the gondola at a position approxi-
mately corresponding to the vertical level of the subjects’ 
heart. Throughout each experiment, the subject was moni-
tored via closed-circuit television, and was able to commu-
nicate with the experimenter by means of a two-way inter-
com system.
The anti-G ensemble used in the Gripen 39 aircraft 
(AGE 39) has been described in detail elsewhere (Eiken 
et al. 2007, 2011). It comprises a pressure-breathing system 
and an extended coverage pneumatic anti-G suit, which 
contains a single-compartment inflatable bladder, fully cov-
ering the lower abdomen as well as the legs, from below 
the gluteal region and the inguinal ligaments to the ankles. 
For the purpose of the present experiments, a modified ver-
sion of the anti-G suit was used, in which it was possible 
to pressurise the abdominal and leg portions of the bladder 
separately (cf. Eiken et al. 2011). As in the aircraft, pres-
surisation of the anti-G suit commenced at 2 G, with pres-
sure increasing linearly with increasing G load to reach a 
maximum of 19.1 kPa (143 mmHg) at 5.0 G; at G loads ≤2 
G, the suit was supplied with a “ready pressure” of 1.3 kPa. 
Pressurisation of the airways commenced at 4 G, with a 
stipulated pressure of 1.34 kPa at 5 G. AGE pressures were 
controlled through a G valve/breathing regulator (Eros, 
F-5341, Eros, Plaisir Cedex, France).
Experimental protocols
Series 1
Ten subjects (nine men and one woman; mean ± SD 
age: 36 ± 14 years, height: 181 ± 6 cm, body mass: 
74 ± 13 kg) participated. On a separate occasion, preced-
ing the experimental day, each subject was trained in per-
forming the IOP measurements in the centrifuge gondola 
at 1 G (stationary), using the procedure described below. 
On the experimental day, the subject was instrumented and 
then positioned in the gondola wearing the anti-G suit. He/
she was investigated in four conditions: 2 G, once with the 
full AGS (2-G AGS) and once without the AGS pressur-
ised (2-G NoAGS), and at 3 G with (3-G AGS) and with-
out pressurised AGS (3-G NoAGS). The order of these 
conditions was alternated and balanced among subjects in 
a Latin-square manner. Each experimental trial started with 
4 min of baseline measurements at 1 G. Thereafter, the G 
load was increased by 0.5 G/s to a plateau of either 2 or 3 
G. After 4 min at the plateau, the load was decreased to 1 G 
by 0.5 G/s, and measurements continued for another 3 min. 
Successive trials were interspersed by at least a 10-min 
recovery period.
Series 2
Twelve male subjects (age: 30 ± 10 years, height: 
183 ± 4 cm, body mass: 81 ± 7 kg) participated. Each 
subject was instrumented and equipped with the complete 
AGE 39. He was investigated in four conditions: 4 Gz, once 
(a)
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2 Gz
1 Gz 1 Gz
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1 Gz 1 Gz
3 Gz
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Fig. 1  Schematic illustration of the experimental design. The shaded 
zones correspond with the treatment periods (G loading), with the 
light shading referring to complete anti-G-suit (AGS) pressurisation, 
and the dark shading identifying either no AGS pressurisation (a), or 
partial AGS pressurisation (no abdominal bladder; b)
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with the full AGS (including the abdominal bladder) pres-
surised (4-G ABD) and once without the abdominal blad-
der pressurised (4-G NoABD), and at 5 G with and with-
out the abdominal bladder pressurised (5-G ABD and 5-G 
NoABD, respectively). Note that in the 5-G exposures the 
breathing gas was also pressurised (see above). The order 
of the conditions was similarly alternated among subjects 
in a balanced fashion. Each G exposure started with 4 min 
of baseline measurements at 1 G, followed by a G-load 
increase (0.5 G/s) to a 4-min G plateau of 4 or 5 G. After 
4 min, the load was decreased to 1 G by 0.5 G/s, and meas-
urements continued for another 3 min. The G exposures 
were interspersed by at least 10 min of recovery.
Physiological measurements
Heart rate (HR) and arterial pressure HR was derived 
from electrocardiographic recordings using a cardiometer 
(Datex-Engström, Instrumentation Corp, Helsinki, Finland), 
and with the electrodes positioned in a precordial 5-lead 
arrangement. Systolic (SAP), diastolic (DAP) and mean 
(MAP) arterial pressures were measured using a volume-
clamp technique (Portapres, TNO, Amsterdam, The Neth-
erlands) with the pressure cuff placed around the middle-
phalanx of the third finger of the right hand, and with the 
reference pressure transducer taped to the skin of the tem-
ple, at the level of the eyes. The right arm was supported by 
an armrest adjusted, so that the distal portions of the fingers 
were at a vertical level corresponding to the jugulum sterni.
Tonometry IOP was measured using a non-contact 
tonometer (Pulsair, Intellpuff, Keeler, UK), that was 
mounted on a custom-made horizontal slide, positioned 
in the centrifuge gondola with the tonometer transducer 
at the vertical and transversal levels of the subject’s left 
eye. The subject could move the tonometer in the sagit-
tal direction, along a frictionless track; the tonometer was 
spring-loaded, so that it retracted away from the face when 
the subject released his/her grip of it. The tonometer was 
provided with a video camera (Plexgear USB Microscope) 
and a miniature video screen (7 inch TFT LCD Monitor), 
enabling the subject, using his/her right eye, to place the 
tonometer in the correct position for IOP measurement of 
his/her left eye. IOP readings were monitored via a stand-
ard CCD video camera. The subject was instructed to con-
duct as many IOP measurements as possible during the 
course of each intervention. Typically, due to nystagmus, 
IOP measurements could not be performed during, and for 
a few seconds following, each G transition.
Capillary oxyhaemoglobin saturation (SpO2) SpO2 was 
measured continuously throughout all trials using a pulse 
oxymeter (Nellcor Puritan Bennett Inc., Pleasanton, CA, 
USA), with the transducer placed on the second finger of 
the right hand. The oxymeter has an accuracy of ±2% units 
across the range 70–100% and an acceptable resilience to 
motion artefacts.
Cerebral oxygenation Throughout each experiment, the 
oxygenation of the frontal cerebral cortex was measured 
using continuous-wave NIRS (NIRO-200NX, Hamamatsu, 
Japan). The transducer unit was positioned over the left 
prefrontal cortex between the first frontal-polar (Fp1) and 
the third frontal (F3) locations, as determined using the 
modified international 10–20 system for electroencepha-
lograms. To minimise confounding influence of skin blood 
flow, the unit, which consists of an emitter and a detec-
tor, was taped to the skin at a fix inter-optode distance of 
4.0 cm (Hampson and Piantadosi 1988). To reduce intru-
sion of external light and loss of transmitted NIR light from 
the measuring area, the transducer unit was covered with an 
opaque bandage.
The NIR light is comprised of three wavelengths (735, 
810 and 850 nm), and changes in tissue oxygenation were 
calculated as oxygenated (∆[O2Hb]) and deoxygenated 
(∆[HHb]) haemoglobin (Hb), respectively. In addition, 
total Hb (∆[THb]), which is the sum of ∆[O2Hb] and 
∆[HHb], and reflects changes in regional blood volume 
(Van Beekvelt et al. 2001), was calculated continuously. 
The theory, limitations, and reliability of cerebral oxygena-
tion obtained employing NIRS have been reviewed else-
where (Boushel et al. 2001; Ferrari et al. 2004). The NIRS 
signal was recorded at 5 Hz and expressed relative to the 
4-min baseline period preceding each trial.
Analyses
Data obtained during and after the G plateaux were aver-
aged every 15 s. However, because of large inter-individual 
variability regarding the number of IOP measurements dur-
ing the G exposures, IOP values were averaged for each 
min within subjects.
Statistical analyses were performed using Statistica 
8.0 (StatSoft, Tulsa, OK, USA). All data are reported as 
mean ± SD, unless otherwise indicated. Analysis of the 
normal distribution of the data was performed with the Kol-
mogorov–Smirnov test. The statistical significance of dif-
ferences was evaluated by a two-way (condition × time) 
general linear model repeated measures analysis of vari-
ance (ANOVA). Mauchly’s test was conducted to assess the 
sphericity, and the Greenhouse-Geisser correction was used 
to adjust the degrees of freedom when the assumption of 
sphericity was not satisfied. The Tukey honestly significant 
difference post hoc test was employed to identify specific 
differences between means when ANOVA revealed a sig-
nificant F ratio for interaction or main effects. Probabilities 
<0.05 were regarded as being statistically significant.
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Results
All experiments were conducted without adverse events; 
none of the subjects experienced G-LOC.
Series 1
Arterial pressure and heart rate In all trials, MAP dropped 
instantly upon G exposure, reaching a nadir value ~15 s 
into the G plateau (Fig. 2a). That drop was followed by a 
gradual increase with a complete recovery (p > 0.05) to 
baseline MAP during both trials conducted with the AGS 
pressurised (after ~120 s at 2 G and ~75 s at 3-G AGS). 
Without suit pressurisation (NoAGS trials), only a partial 
recovery was observed (p < 0.05). Throughout the G pla-
teau, MAP was consistently lower in the 3-G NoAGS than 
in the other trials (p < 0.001). Upon returning to 1 G, MAP 
promptly reverted to baseline values in all trials (p > 0.05).
During the G exposure, SAP decreased in both NoAGS 
trials, but remained unchanged in the AGS trials (Table 1). 
Each G exposure reduced DAP and elevated HR (p < 0.05), 
with changes being more pronounced in the 3-G NoAGS 
than in the other trials (p < 0.01; Table 1).
Capillary oxyhaemoglobin saturation SpO2 remained 
unchanged during the 2-G NoAGS trial (p > 0.05; Fig. 2b). Dur-
ing the 3-G AGS trial, SpO2 dropped and levelled off within 
~75 s; whereas in the 2-G AGS and 3-G NoAGS trials, SpO2 
decreased to a stable level within ~90 s (p < 0.05). Following 
those G exposures, SpO2 gradually recovered in a trial-depend-
ent manner, such that it had resumed baseline values within ~30, 
~45, and ~90 s in the 2-G AGS, 3-G NoAGS, and 3-G AGS 
trials, respectively. During the G plateau and the initial part of 
recovery, the reduction in SpO2 was substantially greater in the 
3-G AGS than in the other trials (p ≤ 0.01). SpO2 was also lower 
in the 3-G NoAGS than in the 2-G NoAGS trial (p = 0.02).
Cerebral oxygenation In all trials, ∆[O2Hb] dropped 
instantly upon G exposure, reaching a nadir value ~15 s 
into the plateau period (p < 0.01; Fig. 2c). During the 
remaining course of the G plateau, ∆[O2Hb] did not exhibit 
any further significant change in any of the trials (p > 0.05). 
Throughout the G plateau, ∆[O2Hb] was consistently lower 
in the 3-G NoAGS than in the other trials (p < 0.05), and 
lower in the 3-G AGS than in both 2-G trials (p ≤ 0.05). 
Upon return to 1 G, ∆[O2Hb] rebounded promptly; dur-
ing the recovery phase, ∆[O2Hb] was greater in the 3-G 
NoAGS trial than in the other trials (p ≤ 0.05).
During the G exposure, ∆[HHb] did not change in any 
of the trials (p > 0.05; Table 1). ∆[THb] decreased by 
~135, ~303. and ~261% in 2-G NoAGS, 3-G NoAGS, and 
3-G AGS trials, respectively (p < 0.05; Table 1). ∆[THb] 
was reduced by ~134% in the 2-G AGS trial, although that 
difference was not statistically significant (p = 0.88). The 
drop in ∆[THb] was greater in the 3-G NoAGS than in the 
3-G AGS trial (p < 0.001).
Intraocular pressure No statistically significant differ-
ence in IOP was detected between 1-G baseline periods 
and the 4-min periods at the 2- and 3-G plateaux (p = 0.09; 
Table 2). No difference was observed between the trials 
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Fig. 2  Mean (SE) arterial pressure (MAP; a), capillary oxyhaemo-
globin saturation (SpO2; b) and changes from resting values in cer-
ebral oxyhaemoglobin (∆[O2Hb]; c) obtained during the 4-min G 
plateaux at 2 and 3 G, and the 3-min recovery with (AGS) and with-
out (NoAGS) anti-G-suit pressurised. B baseline phase, T transition 
(G onset) phase. *Significantly different from 2-G NoAGS, 2-G 
AGS, and 3-G AGS, †significantly different from 2-G NoAGS, ‡sig-
nificantly different from 2-G AGS, §significantly different from 2-G 
NoAGS, 2-G AGC, and 3-G NoAGS (p ≤ 0.05). n = 10
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Series 2
Arterial pressure and heart rate In all trials, MAP dropped 
instantly upon G exposure, reaching a nadir value ~15 s 
into the G plateau phase (p < 0.001; Fig. 3a). Thereafter, 
MAP gradually recovered, especially in the ABD trials, but 
remained below baseline values throughout the G plateau 
(p < 0.001). MAP was higher in the 4-G ABD than in either 
of the other trials (p < 0.05). It was also slightly higher 
in the 5-G ABD than in the 5-G NoABD trial, although 
that difference was not significant (p = 0.61). During the 
recovery phase, MAP reverted to baseline values within 
~45 s, and no differences were observed between the trials 
(p > 0.05).
During the G exposures, SAP and DAP were substan-
tially reduced (p ≤ 0.05); no differences were observed 
between the trials (p > 0.05; Table 3). HR was elevated in 
all trials, and that increase was greater in the 5-G than the 
4-G trials (p ≤ 0.001; Table 3).
Capillary oxyhaemoglobin saturation In all trials, SpO2 
dropped and levelled off within ~60 s of high-G onset 
(p < 0.001), and recovered within ~90 s upon returning to 
1 G (Fig. 3b). SpO2 was lower in the 5-G NoABD than in 
the 4-G NoABD trial (p = 0.02). Pressurisation of the AGS 
abdominal bladder aggravated the G-induced reduction in 
SpO2, with SpO2 being substantially lower in the 5-G ABD 
than in the other trials (p < 0.001). It was also lower in the 
4-G ABD than in the 4-G NoABD and 5-G NoABD trials 
(p < 0.01).
Cerebral oxygenation In all trials, ∆[O2Hb] dropped 
promptly upon each G exposure (p < 0.001; Fig. 3c), and 
the reduction was more pronounced at 5 G than at 4 G 
(p < 0.001). During both 4-G trials and also during the 5-G 
NoABD trial, ∆[O2Hb] dropped and levelled off within 
15 s of the G onset. In the 5-G ABD trial, however, the 
initial drop in ∆[O2Hb] was followed by a further gradual 
decrease with the nadir value being attained at the end of 
the G exposure. Upon return to 1 G, ∆[O2Hb] rebounded 
within ~30 s in all trials; yet, in the 5-G ABD trial, the 
recovery of ∆[O2Hb] was slightly slower than in the 4-G 
trials (p < 0.05). During the recovery phase, ∆[O2Hb] was 
higher following 5-G NoABD than following the other tri-
als (p < 0.05).
During these G exposures, ∆[HHb] did not change in 
any of the trials (p > 0.05; Table 3). ∆[THb] was substan-
tially reduced in all trials (p < 0.001), and especially within 
the 5-G trials (p < 0.01; Table 3).
Discussion
Present results demonstrated that IOP was but minimally 
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gravitoinertial load in the head-to-foot direction. By contrast, 
each high-G exposure induced a prompt reduction in cerebral 
oxygenation, the magnitude of which was dependent both on 
the size of the step-change in G load and on whether, and 
what kind of, G-protective garment the subject was using. In 
the 4- and 5-G exposures, the initial depression of cerebral 
oxygenation prevailed at a steady level, or oxygenation even 
tended to drop further during the course of the 4-min G pla-
teaux. This response occurred despite the fact that the initial 
decline in local arterial pressure was followed by a partial 
recovery during the latter two-thirds of the plateau.
These results should be viewed in the context of our 
previous study (Eiken and Grönkvist 2013), which showed 
that the risks of near and actual loss of consciousness are 
several-fold greater if pressure in the anti-G system is lost 
after a 2-min period of sustained high-G load than if the 
system fails to elevate pressure during onset of such G 
loading, presumably because in the former condition loss 
of consciousness is not always preceded by impeded vision. 
This raises the question of whether prolonged exposure 
to elevated but tolerable G loads either reduces the risk of 
G-induced loss of vision, or increases the risk of G-induced 
cerebral dysfunction.
Intraocular pressure at increased G load
Judging from our finding that the IOP was virtually unaf-
fected by a threefold increase in G load, it appears unlikely 
that prolonged exposure to high, but tolerable, G loads 
might reduce the susceptibility to decrements in peripheral 
and central vision upon exposure to supra-tolerance loads. 
Thus, it has long been recognised that the G-induced loss 
of peripheral and foveal visions, commonly referred to 
by pilots as “grey out” and “black out”, respectively, are 
caused by retinal ischaemia resulting from insufficient per-
fusion pressure in intraocular blood vessels (Duane 1954; 
Lambert and Wood 1946; Newsom and Leverett 1968); 
once MAP drops below IOP, retinal perfusion ceases (Riva 
et al. 1986).
A sustained reduction of arterial pressure may, in turn, 
reduce IOP (Mitchell et al. 2005), but the magnitude of 
any IOP drop induced by a sustained decrease in arterial 
pressure, will amount to a mere fraction of the actual drop 
in arterial pressure (Mitchell et al. 2005; Nicholson et al. 
1968). Consequently, the only conceivable period during 
which an MAP-induced drop in IOP might predispose to 
increased ocular perfusion pressure, is the transient period 
between regaining MAP and the ensuing readjustment of 
the IOP to the elevated MAP. At the outset of the present 
experiments, we reasoned that improved provisions for reti-
nal blood flow might occur during prolonged G exposure, 
either by way of a transient overshoot in retinal perfusion 
pressure following the recovery of MAP after its tran-
sient initial drop, or by another unforeseen mechanism. It 
appears, however, that IOP is rather resilient to G-induced 
decrements in local arterial pressure. Thus, even at 3 G 
without pressurised anti-G suit, IOP exhibited a minimal 
drop, despite MAP stabilising at about 20 mmHg below the 
baseline (1-G) level. Whether the G-induced drops in MAP 
were of sufficient magnitude and duration to significantly 
affect IOP remains to be established.
Bakke et al. (2009) showed that a 2-min isometric 
exercise bout resulting in an MAP increase from 80 to 
120 mmHg was paralleled by a 4-mmHg increase in IOP, 
whereas a decrease in local MAP of 20–25 mmHg accom-
panying a postural change from recumbent to sitting results 
in a rapid decrease in IOP (Krieglstein and Langham 
1975), that may vary considerably in magnitude, with aver-
age changes reported in different studies ranging from 0.3 
to 2.9 mm Hg (cf. Anderson and Grant 1973; Jain and Mar-
mion 1976; Krieglstein and Langham 1975). In addition, 
long-term changes in arterial pressure appear to result in 
IOP changes of similar magnitude, with a 1-mmHg change 
in IOP for every 30-mmHg change in SAP (Mitchell et al. 
2005). The reason for the large inter-study variations in 
IOP response to a 20–25 mmHg drop in local arterial pres-
sure remains to be settled, as does the reason for the minute 
IOP change in response to a 20-mmHg drop in local MAP 
in the present 3-G exposures. The non-contact tonometry 
technique used in the present study is regarded a reproduc-
ible and sensitive means of measuring IOP (Almubrad and 
Ogbuehi 2010; Jain and Marmion 1976).
Table 2  Mean values ± SD as well as (total number of measurements) of intraocular pressure obtained during the 4-min baseline, the 4-min 
plateau at 2 and 3 G, and the 3-min recovery period, with (AGS) and without (NoAGS) the anti-G-suit pressurised
n = 10
Baseline G plateau Recovery
1 min 2 min 3 min 4 min
2-G NoAGS 14.1 ± 1.6 (291) 14.1 ± 1.6 (61) 14.1 ± 1.57 (89) 14.0 ± 1.6 (91) 14.0 ± 1.6 (94) 14.2 ± 1.6 (239)
2-G AGS 14.1 ± 1.6 (320) 14.1 ± 1.6 (52) 14.0 ± 1.56 (74) 14.0 ± 1.6 (67) 14.1 ± 1.6 (101) 14.2 ± 1.6 (210)
3-G NoAGS 14.1 ± 1.6 (362) 14.1 ± 1.6 (36) 14.1 ± 1.58 (70) 14.1 ± 1.6 (65) 14.0 ± 1.6 (80) 14.1 ± 1.6 (220)
3-G AGS 14.1 ± 1.7 (308) 14.1 ± 1.7 (51) 14.1 ± 1.66 (84) 14.1 ± 1.6 (69) 14.1 ± 1.6 (69) 14.1 ± 1.7 (207)
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Cerebral oxygenation at increased G load
The second main aim of the present experiments was to 
investigate the effects of sustained moderate elevations of G 
load on the cerebral anoxia reserve. Oxygen delivery to the 
frontal cortex is determined by the local blood flow and the 
arterial oxygen content. As expected, all sustained G-load 
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Fig. 3  Mean (SE) arterial pressure (MAP; a), capillary oxyhae-
moglobin saturation (SpO2; b) and changes from resting values in 
cerebral oxyhaemoglobin (∆[O2Hb]; c) obtained during the 4-min 
G plateaux at 4 and 5 G, and the 3-min recovery, with (ABD) and 
without (NoABD) the abdominal bladder of the anti-G-suit inflated. 
B baseline phase, T transition (G onset) phase. *Significantly differ-
ent from 4-G NoABD and 4-G ABD, †significantly different from 
4-G NoABD, 4-G ABD, and 5-G NoABD, ‡significant difference 
between 4-G NoABD and 4-G ABD, §significant difference between 
4-G NoABD and 5-G NoABD, ¶significant difference between 4-G 
ABD and 5-G NoABD, **significant difference between 4-G ABD 
and 5-G ABD, ††significant difference between 5-G NoABD and 5-G 
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increments induced an immediate drop in eye-level MAP, 
which then partially recovered, but nevertheless stabilised 
considerably below its 1-G baseline value, during the lat-
ter two-thirds of the G plateaux. By contrast, frontal cortex 
oxygenation (∆[O2Hb]) decreased promptly upon high-G 
exposure and did not recover during the ensuing course of 
the G plateau; during the 5-G exposure, with pressurisation 
of the full AGS, including the abdominal bladder, the ini-
tial drop in frontal cortex oxygenation was even followed 
by a slight but further drop in oxygenation. That ∆[O2Hb] 
remained reduced throughout the G exposure may be attrib-
uted to two mechanisms, reduced local blood flow and 
hypoxaemia.
In the 4- and 5-G trials, the steady-state eye-level MAP 
varied between 30 and 45 mmHg and was dependent not 
only on the G load but also of whether the G-suit abdomi-
nal bladder was pressurised, with a distinctly higher MAP 
at a given G load, when the bladder was pressurised. Cer-
ebral blood flow is predominantly autoregulated, vascu-
lar myogenic tone being governed by a complex interplay 
between responses to local changes in transmural pressure 
and the chemical environment, but also being modified by 
regional vascular conducted responses (cf Jensen and Hol-
stein-Rathlou 2013). Particularly in dynamic conditions, 
the interplay between autoregulatory mechanisms is not 
fully understood (cf. Panerai et al. 2002). Regardless, it is 
clear that the cerebral vasculature regulates flow across a 
wide range of perfusion pressures, whereas under 1-G con-
ditions, its autoregulatory capacity is exceeded once local 
arterial pressure drops below about 60 mmHg (Testart 
1990). Thus, it is reasonable to assume that in the pre-
sent 4- and 5-G exposures, cerebral blood flow remained 
reduced throughout the high-G plateaux.
The reduction in cerebral blood flow resulting from the 
G-induced drop in local arterial pressure might have been 
modulated by two mechanisms, acting in opposite direc-
tions. On the one hand, at increased G loads, cerebral per-
fusion pressure is influenced by the siphon effect (Henry 
et al. 1951). Since intracranially, venous walls are not as 
collapsible as in other regions of the body, local venous 
pressure may assume subatmospheric levels during head-
ward acceleration. Hence, antegrade flow may prevail in 
cerebral vasculature even in the face of a G-induced drop 
in local arterial pressure to or below 0 mmHg (Henry et al. 
1951). Even though the existence of the siphon effect is 
well established (Green 2016), it is difficult to quantify its 
role at different G loads, since data of intracerebral venous 
pressures in humans exposed to such conditions are scarce. 
On the other hand, it can be presumed that the G-induced 
hypoxaemia led to hyperpnoea and therefore to hypocap-
nia. Although hypocapnia constitutes a potent stimulus for 
cerebral vasoconstriction (Shapiro et al. 1970), it appears 
unlikely that it was capable of overriding the vasodilatory 
effect of the G-induced drop in local precapillary trans-
mural pressure. Thus, the prompt overshoot in frontal cor-
tex oxygenation upon cessation of G exposure probably 
reflected a concomitant surge in cerebral blood flow and 
hence suggests that local precapillary resistance vessels 
were dilated upon release of the G load. Similar overshoot 
responses in ∆[O2Hb], reflecting a post-ischaemic reactive 
hyperaemia phase, have been noted following cessation of 
short-duration high +Gz loads (Kobayashi et al. 2012) and 
in particular following exposures inducing G-LOC (Ryoo 
et al. 2004).
The present G-induced hypoxaemia is attributable 
to pulmonary atelectasis and consequent shunting of 
deoxygenised blood in dependent portions of the lungs 
(Barr 1962, 1963; Glaister 1970). Thus, the G-dependent 
intrathoracic hydrostatic pressure gradient results in basal 
redistribution of the intrapulmonary blood volume and 
compression of basal alveoli (Barr 1963; Dussault et al. 
2016; Glaister 1970). Our finding that the G-induced 
hypoxaemia was exaggerated by inflation of the AGS 
abdominal bladder is also in agreement with results from 
previous studies (Barr 1963) and supports the notion that 
G-induced hydrostatic compression atelectasis is aggra-
vated by transmission of pressure from the AGS to the 
abdominal cavity and the lower thorax (Eiken et al. 2011). 
It should be noted that the magnitude and time courses of 
the present G-induced hypoxaemia episodes, as reflected 
by the decrements in capillary oxygen haemoglobin satu-
ration in a fingertip, should be interpreted with caution. 
As obvious from the SpO2 curve upon G offset, changes in 
oxyhaemoglobin saturation induced in the pulmonary cir-
culation will appear in the fingertip with a delay of at least 
30 s. In the cerebral vessels, the delay time is substantially 
shorter, and, in all likelihood, the magnitude of the satura-
tion drop is larger than in the capillaries of a finger (cf. 
Lindholm et al. 2007).
It appears that in the present 4- and 5-G exposures (but 
not in the 2- and 3-G exposures), the hypoxaemia was suffi-
ciently severe to counteract any recovery of cerebral deox-
ygenation despite the considerable recovery of cerebral 
perfusion pressure during the latter part of the exposure. 
In fact, in the condition most relevant from an operational 
viewpoint, namely 5 G with full anti-G garment, ∆[O2Hb] 
continued to drop by about 40% during the course of the G 
load (from −10 to −14 μM). Judging from the consider-
able difference in ∆[O2Hb] between the 4- and 5-G ABD 
trials, it seems reasonable to assume that the continuous 
drop in ∆[O2Hb] during the course of the G plateau might 
be more pronounced at loads exceeding 5 G.
Thus, progressive reduction of the cerebral anoxia 
reserve during the exposure to sustained high G whilst 
wearing full anti-G-protective garment remains a plausible 
explanation to our previous finding that the risk of G-LOC 
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was several-fold higher when the pressure in the G-protec-
tive system was lost after a prolonged period of sustained 
exposure to +6 Gz than when pressure failed to increase in 
conjunction with the onset of +6 Gz (Eiken and Grönkvist 
2013). In this connection, it should be noted that the reti-
nal anoxia reserve, by contrast, appears rather resilient to 
hypoxaemia. Thus, a preceding period of moderate hypoxia 
does not seem to affect the latency period from complete 
blocking of retinal blood flow to loss of vision (Lambert 
and Bjurstedt 1962).
Information is scarce regarding oxygenation responses 
of the frontal cortex to prolonged periods of sustained high-
G loads. In the present 5-G exposures, ∆[O2Hb] dropped by 
about 14 μM, which should be compared to the 20–23 μM 
decrements reported in conjunction with brief +Gz expo-
sures resulting in G-LOC (Kurihara et al. 2007; Tripp et al. 
2009). It should be noted, however, that although ∆[O2Hb] 
appears to be a valid predictor of A-LOC and G-LOC (Kur-
ihara et al. 2007; Ryoo et al. 2004; Tripp et al. 2009), the 
relative drop in ∆[O2Hb] at which A-LOC/G-LOC occurs 
varies considerably between studies [e.g., from −6 to 
−7% in the study by Ryoo et al. (2004) to −32 to −33% 
in the study by Kurihara et al. (2007)]. Presumably, these 
inter-study variations are mainly attributable to methodo-
logical differences, including spectrometer performance, 
inter-optode distance, and transducer position. Regard-
less, inter-study comparisons of ∆[O2Hb] in response to G 
exposure should be conducted with caution.
Study limitations and delimitations
Arguably, the present study lacked sufficient statistical 
power to rule out the possibility that increased +Gz load-
ing may reduce IOP. From a practical viewpoint, it appears, 
however, that any IOP change induced by slight-to-moderate 
+Gz elevations is too small to have significant consequences 
(Fig. 4). Present G exposures consisted of 4-min plateaux 
at ≤ +5 Gz. From an operational viewpoint, it is important 
that these data are supplemented with data from G exposures 
comprising simulated aerial combat manoeuvres (SACM), 
during which the G loading is alternated (e.g., every 15 s) 
between moderate (e.g., 4.5 G) and high (e.g., 7 G). Judg-
ing from previous studies, long-duration SACM will induce 
similar levels of hypoxaemia (Balldin and Siegborn 1992), 
and hence presumably also of frontal cortex hypoxia, as 
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Fig. 4  Individual mean values, and group averages (bold curves), of intraocular pressure (IOP) obtained during the 4-min G plateaux at 2 and 3 
G, and the 3-min recovery with (AGS) and without (NoAGS) anti-G-suit pressurised. B baseline phase, R recovery phase. n = 10
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G exposures. In-flight recordings from a few F-15 pilots 
seem to suggest that, during ACM, cerebral oxygenation 
decreases in response to both the peak load and duration of 
the ACM (Kobayashi et al. 2002). Consequently, it is reason-
able to assume, but remains to be established, that currently 
observed gradually diminishing cerebral oxygenation at ele-
vated G load might also occur during long-duration SACM. 
Furthermore, it remains to be investigated whether, and in 
what manner, pressure breathing, G load, and G-suit pres-
surisation interact as regard both intrapulmonary shunting of 
deoxygenized blood and cerebral oxygenation. In the present 
study, the increase in G load from 4 to 5 G was accompanied 
not only by an increase in anti-G-suit pressure, but also by 
application of positive pressure breathing.
Conclusions
Prolonged exposure to light-moderate +Gz elevation did 
not affect intraocular pressure but induced a sustained 
reduction in cerebral oxygenation, despite a concomitant 
partial recovery of mean arterial pressure. That cerebral 
oxygenation remained suppressed throughout these expo-
sures is attributable to pulmonary shunting of deoxygen-
ized blood into the systemic arteries, and suggests that 
the increased risk of G-LOC upon G-garment failure after 
prolonged G exposure is due to a reduction in the cerebral 
anoxia reserve.
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